FatiguE in Sjögren’s Syndrome: a randomised controlled trial of cOmbined Non-phArmacological therapeutic strategies (FESSONA)
Xinyao Zhou(Université Claude Bernard Lyon 1), Martin Killian(Université Claude Bernard Lyon 1), Claire Colas(Inserm), David Hupin(Université Claude Bernard Lyon 1), Jinzhou Chen(Meizhou City People's Hospital)
Cited by 3
Related Papers
Even a low-dose of moderate-to-vigorous physical activity reduces mortality by 22% in adults aged ≥60 years: a systematic review and meta-analysis
|British Journal of Sports Medicine|2015|566
Management of Long COVID—The CoviMouv' Pilot Study: Importance of Adapted Physical Activity for Prolonged Symptoms Following SARS-CoV2 Infection
|Frontiers in Sports and Active Living|2022|39
Physical Activity in Long COVID: A Comparative Study of Exercise Rehabilitation Benefits in Patients with Long COVID, Coronary Artery Disease and Fibromyalgia
|International Journal of Environmental Research and Public Health|2023|35
Understanding Experiences of Fibromyalgia Patients Involved in the Fimouv Study During COVID-19 Lockdown
|Frontiers in Psychology|2021|29